tide seemed to be stemmed, page-58

Some of the industries OBJ is targetting are worth billions per year.
They only need to get revenues of $25,000,000.00 per annum and at a PE of 10 the shares are worth 5cents each after expenses and tax.
The tooth patch industry alone is worth $11,000,000,000.00 PA.
OBJ's tooth patch is 48% better then anything on the market.
If it earns just 1/4 of 1 % of world revenues then fully diluted and taking into account the issuing of another 100,000,000 shares makes earnings of 2.5cents per share.A PE of 5 in that scenario makes the shares worth 12.5cents.

the numbers are mindboggling.
they appear to have proved the patches work.
next step is commercialisation.
can you afford not to be in at these levels?
I dont think so and so i am in heavily.
Others dont see it happening or dont understand or just dont want to be in a BIO for the long haul.
Those of us in now are set but there is still opportunity.waiting for an announcement may mean getting in a 4 cents instead of 1cent.
If they sign a deal (which i believe they will soon) then this will skyrocket.

Azopharma shows that the patch they tested (with an over the counter substance that has large worldwide sales,)was 10 times better then anything else on the market.

With individual licensing in place the figres become unbelieveable and if it comes to fruition we are talking massive revenues.
can these go to those sorts of heights?well Biotechs are the ones that can do it.
PRR went like a rocket and i believe OBJ will too eventually.
In at these levels seems a bet to nothing.